A groundbreaking HIV cure trial in South Africa has sparked global optimism. Led by Professor Thumbi Ndung’u from the University of KwaZulu-Natal and the Africa Health Research Institute (AHRI), the study achieved a 20% success rate in enabling participants to stay off antiretroviral therapy (ART) while maintaining viral suppression. This marks a pivotal step toward long-term HIV remission.
A South African HIV Cure Trial Achieves 20% Success Rate
March 19, 2025
(updated March 19, 2025)
Published by Jean Paul
